- Home
- UPLD vs PSTV Comparison
UPLD vs PSTV Comparison
Compare UPLD & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UPLD | PSTV |
|---|---|---|
| Founded | 2010 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.0M | 61.1M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | UPLD | PSTV |
|---|---|---|
| Price | $1.44 | $0.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $4.50 | ★ $7.25 |
| AVG Volume (30 Days) | 192.2K | ★ 4.5M |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $235,591,000.00 | $5,258,000.00 |
| Revenue This Year | N/A | $1.73 |
| Revenue Next Year | N/A | $12.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.40 | $0.16 |
| 52 Week High | $4.98 | $2.31 |
Technical Indicators
Market Signals| Indicator | UPLD | PSTV |
|---|---|---|
| Relative Strength Index (RSI) | 28.86 | 42.71 |
| Support Level | $1.40 | $0.54 |
| Resistance Level | $1.53 | $0.58 |
| Average True Range (ATR) | 0.09 | 0.05 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 3.26 | 3.99 |
Price Performance
Historical ComparisonAbout UPLD Upland Software Inc.
Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).